P140029S022

None

FDA Premarket Approval P140029 S022

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP140029S022
Classification NameNone
Applicant
PMAP140029
SupplementS022

Supplemental Filings

Supplement NumberDateSupplement Type
P140029Original Filing
S026 2020-06-04 30-day Notice
S025 2020-04-21 Special (immediate Track)
S024 2020-02-18 30-day Notice
S023 2020-01-21 30-day Notice
S022
S021 2019-09-03 Panel Track
S020 2019-08-15 30-day Notice
S019
S018
S017 2019-05-17 Real-time Process
S016 2019-02-14 30-day Notice
S015 2018-10-22 30-day Notice
S014 2018-09-19 30-day Notice
S013 2018-08-23 30-day Notice
S012 2018-06-01 30-day Notice
S011 2018-05-25 30-day Notice
S010 2018-05-23 30-day Notice
S009 2018-05-18 30-day Notice
S008 2018-05-16 30-day Notice
S007 2018-04-26 Real-time Process
S006 2017-12-18 135 Review Track For 30-day Notice
S005
S004 2017-06-14 Normal 180 Day Track No User Fee
S003 2017-06-08 30-day Notice
S002
S001 2017-01-11 135 Review Track For 30-day Notice

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.